Cargando…
The Comprehensive Analyses of Genomic Variations and Assessment of TMB and PD-L1 Expression in Chinese Lung Adenosquamous Carcinoma
The poor prognosis and fewer treatment option is a current clinical challenge for patients with lung adenosquamous carcinoma (ASC). The previous studies reported that tumor mutational burden (TMB, numbers of mutation per Megabase) is a predictor of clinical response in trials of multiple cancer type...
Autores principales: | Cheng, Yong, Zhang, Yanxiang, Yuan, Yuwei, Wang, Jiao, Liu, Ke, Yu, Bin, Xie, Li, Ou-Yang, Chao, Wu, Lin, Ye, Xiaoqun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925901/ https://www.ncbi.nlm.nih.gov/pubmed/33679868 http://dx.doi.org/10.3389/fgene.2020.609405 |
Ejemplares similares
-
Genomic Variations and Immune-Related Features of TMB, PD-L1 Expression and CD8(+) T Cell Infiltration in Chinese Pulmonary Sarcomatoid Carcinoma
por: Zhang, Chenyue, et al.
Publicado: (2022) -
Cuproptosis-related LncRNAs are correlated with immunity and predict prognosis in HNSC independent of TMB
por: Li, Mingyu, et al.
Publicado: (2023) -
Comprehensive analyses of genomic features and mutational signatures in adenosquamous carcinoma of the lung
por: Wang, Hongbiao, et al.
Publicado: (2022) -
Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project
por: Merino, Diana M, et al.
Publicado: (2020) -
Identification of Crucial Gene Modules Related to the Efficiency of Anti-PD-1/PD-L1 Therapy and Comprehensive Analyses of a Novel Signature Based on These Modules
por: Wang, Wei, et al.
Publicado: (2022)